See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Pete Hegseth
Social Media
Senate
Republican Party
Democratic Party
Amazon
World Cup
Artificial Intelligence
Natural Disasters
US Politics
Donald Trump
Published • loading... • Updated

New non-opioid anti-pain pill approved by FDA

Summary by La Crosse Tribune
The Food and Drug Administration recently approved a new, non-opioid (non-narcotic) prescription pill, suzetrigine (SUE-zeh-TRY-gene). It will be sold under the brand name Journavx (JOUR-nahvix) to treat moderate to severe, acute, short-term pain in adults.

1 Articles

All
Left
Center
1
Right
La Crosse TribuneLa Crosse Tribune
Center

New non-opioid anti-pain pill approved by FDA

The Food and Drug Administration recently approved a new, non-opioid (non-narcotic) prescription pill, suzetrigine (SUE-zeh-TRY-gene). It will be sold under the brand name Journavx (JOUR-nahvix) to treat moderate to severe, acute, short-term pain in adults.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

La Crosse Tribune broke the news in on Saturday, March 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

FDA

FDA

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal